Inovio Pharmaceuticals Inc (NASDAQ:INO), closed its previously announced underwritten public offering of 10,925,000 shares of the Company’s common stock, including 1,425,000 shares of …
Inovio Pharmaceuticals Inc (Nasdaq:INO), announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & …
Inovio Pharmaceuticals Inc (Nasdaq:INO) announced that it was recognized with a prestigious industry award at the World Vaccine Congress being held this week in Washington, …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) …
Inovio Pharmaceuticals, Inc. (Nasdaq:INO) announced today that Chief Operating Officer, Dr.
Inovio Pharmaceuticals Inc (Nasdaq:INO) announced the appointment of Scott M. White, M.
In a research report released on Monday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Inovio Pharmaceuticals Inc (NASDAQ:INO) with a …
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that the company and its academic collaborators, including the University of Pennsylvania(UPenn), were awarded a new five-year $16 …
Chicago IL / Research Report Wire / February 27th, 2015 / Institutional Analyst Inc.(IA) announced today it released the its Top 20 Biotech …
